Abstract
Calcitonin gene related peptide (CGRP) is a mediator of neurogenic inflammation playing a major role in the pathogenesis of migraine. Increases in serum CGRP have been detected previously in migraineurs and a return to baseline values regarded as successful treatment. As gingival crevicular fluid is known to originate from the serum, the aim of this study is to measure the CGRP content of gingival crevicular fluid (GCF) in chronic migraine patients and to determine whether there is a correlation between serum and GCF values of CGRP. For this study, 24 female individuals suffering from chronic migraine with aura were age-matched with 15 healthy individuals. Serum and GCF samples were obtained from both groups and enzyme linked immunosorbent assay performed to measure CGRP concentration. The level of CGRP in the serum and GCF of chronic migraine patients was 41 ± 16 pg/mL and 0.25 ± 0.09 pg/μg respectively while in healthy individuals CGRP levels were 29 ± 8 pg/mL and 0.19 ± 0.07 pg/μg. The correlation between CGRP levels of the GCF and serum was 0.88 for migraineurs and 0.81 in the controls. Only a weak positive relationship was observed between age and CGRP levels in both groups. CGRP levels were higher in migraineurs compared with controls both in serum and GCF. Furthermore there is a strong correlation between CGRP levels of the serum and GCF. The results of this study suggest that CGRP levels of GCF have potential diagnostic purposes in patients with chronic migraine.
Similar content being viewed by others
References
Stewart WF, Lipton RB, Celentano DD, Reed ML (1992) Prevalence of migraine headache in the United States: relation to age, income, race and other sociodemographic factors. JAMA 267:64–69
Moskowitz MA (1991) The visceral organ brain: implications for the pathophysiology of vascular head pain. Neurology 41:182–186
Goadsby PJ, Edvinsson L (1993) The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 33:48–56
Goadsby PJ, Edvisnson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28:183–187
Edvinsson L, Uddman R (2005) Neurobiology in primary headaches. Brain Res Brain Res Rev 48:438–456
Li J, Vause CV, Durham PL (2008) Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res 1196:22–32
Goadsby PJ, Edvinsson L (1994) Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attack therapies. Brain 117:427–434
Cernuda-Morollón E, Larrosa D, Ramón C et al (2013) Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology 81:1191–1196
Ashina M, Bendtsen L, Jensen R, Schifter S, Jansen-Olesen I, Olesen J (2000) Plasma levels of calcitonin gene-related peptide in chronic tension-type headache. Neurology 55:1335–1340
Frese A, Schilgen M, Edvinsson L, Frandsen E, Evers S (2005) Calcitonin gene-related peptide in cervicogenic headache. Cephalalgia 25:700–703
Cady RK, Vause CV, Ho TW, Bigal ME, Durham PL (2009) Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan. Headache: J Head Face Pain 49:1258–1266
Jang MU, Park JW, Kho HS, Chung SC, Chung JW (2011) Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients. Oral Dis 17:187–193
Kaufman E, Lamster IB (2002) The diagnostic applications of saliva—a review. CROBM 13:197–212
Leppilahti JM, Hernández-Ríos PA, Gamonal JA, Tervahartiala T, Brignardello-Petersen R, Mantyla P, Sorsa T, Hernández M (2014) Matrix metalloproteinases and myeloperoxidase in gingival crevicular fluid provide site-specific diagnostic value for chronic periodontitis. J Clin Periodontol 41:348–356
Ehlers V, Willershausen I, Kraft J, Münzel T, Willershausen B (2011) Gingival crevicular fluid MMP-8-concentrations in patients after acute myocardial infarction. Head Face Med 7:1
Yamaguchi M, Takada R, Kambe S, Hatakeyama T, Naitoh K, Yamazaki K, Kobayashi M (2005) Evaluation of time-course changes of gingival crevicular fluid glucose levels in diabetics. Biomed Microdevices 7:53–58
Noguchi E, Kato R, Ohno K, Mitsui A, Obama T, Hirano T, Itabe H, Yamamoto M (2014) The apolipoprotein B concentration in gingival crevicular fluid increases in patients with diabetes mellitus. Clin Biochem 47:67–71
Awawdeh LA, Lundy FT, Linden GJ, Shaw C, Kennedy JG, Lamey PJ (2002) Quantitative analysis of substance P, neurokinin A and calcitonin gene-related peptide in gingival crevicular fluid associated with painful human teeth. Eur J Oral Sci 110:185–191
Lundy FT, Shaw C, McKinnell J, Lamey PJ, Linden GJ (1999) Calcitonin gene-related peptide in gingival crevicular fluid in periodontal health and disease. J Clin Periodontol 26:212–216
Cernuda-Morollón E, Ramón C, Martínez-Camblor P, Serrano-Pertierra E, Larrosa D, Pascual J (2015) OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine. Pain 156:820–824
Becerik S, Ozçaka O, Nalbantsoy A et al (2010) Effects of menstrual cycle on periodontal health and gingival crevicular fluid markers. J Periodontol 81:673–681
Sardarian A, Andisheh Tadbir A, Zal F, Amini F, Jafarian A, Khademi F, Mostafavi-Pour Z (2015) Altered oxidative status and integrin expression in cyclosporine A-treated oral epithelial cells. Toxicol Mech Methods 25:98–104
Bigal ME, Liberman JN, Lipton RB (2006) Age-dependent prevalence and clinical features of migraine. Neurology 67:246–251
Koka S, Beebe TJ, Merry SP, DeJesus RS, Berlanga LD, Weaver AL, Montori VM, Wong DT (2008) The preferences of adult outpatients in medical or dental care settings for giving saliva, urine or blood for clinical testing. J Am Dent Assoc 139:735–740
Diener HC, Charles A, Goadsby PJ, Holle D (2015) New therapeutic approaches for the prevention and treatment of migraine. Lancet Neurol 14:1010–1022
Edvinsson L (2015) The journey to establish CGRP as a migraine target: a retrospective view. Headache 55:1249–1255
Edvinsson L (2015) CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment. Br J Clin Pharmacol 80:193–199
Wrobel Goldberg S, Silberstein SD (2015) Targeting CGRP: a new era for migraine treatment. CNS Drugs 29:443–452
Bigal ME, Walter S, Rapoport AM (2015) Therapeutic antibodies against CGRP or its receptor. Br J Clin Pharmacol 79:886–895
Barbanti P, Aurilia C, Fofi L, Egeo G, Ferron P (2017) The role of anti-CGRP antibodies in the pathophysiology of primary headaches. Neurol Sci 38(Supplement 1):31–35
Giamberardino MA, Affaitati G, Curto M, Negro A, Costantini A (2016) Martelletti P (2016) Anti-CGRP monoclonal antibodies in migraine: current perspectives. Intern Emerg Med 11:1045–1057
Paemeleire K, MaassenVanDenBrink A (2018) Alcitonin-gene-related peptide pathway mAbs and migraine prevention. Curr Opin Neurol. https://doi.org/10.1097/WCO.0000000000000548
Maasumi K, Tepper SJ, Rapoport AM (2017) New treatments for headache. Neurol Sci 38(Supplement 1):145–156
Funding
The authors of the manuscript would like to thank the vice chancellery of the AJA University of Medical Sciences for the funding of this research (grant number: 2274). We would also like to thank Shiraz University of Medical sciences for their support and facilitation in the process of patient selection and sampling.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Fekrazad, R., Sardarian, A., Azma, K. et al. Interictal levels of calcitonin gene related peptide in gingival crevicular fluid of chronic migraine patients. Neurol Sci 39, 1217–1223 (2018). https://doi.org/10.1007/s10072-018-3340-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-018-3340-3